Q4 2015 13F Holders as of 12/31/2015
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
47.9M
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
51.1M
-
Shares change
-
-1.09M
-
Total reported value, excl. options
-
$1.65B
-
Value change
-
-$35.2M
-
Number of buys
-
86
-
Number of sells
-
-74
-
Price
-
$32.24
Significant Holders of HAEMONETICS CORP - Common Stock (HAE) as of Q4 2015
183 filings reported holding HAE - HAEMONETICS CORP - Common Stock as of Q4 2015.
HAEMONETICS CORP - Common Stock (HAE) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.1M shares
.
Largest 10 shareholders include VANGUARD GROUP INC (3.84M shares), BlackRock Fund Advisors (3.24M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.67M shares), Black Creek Investment Management Inc. (2.59M shares), Neuberger Berman Group LLC (2.39M shares), WELLS FARGO & COMPANY/MN (2.28M shares), WESTWOOD HOLDINGS GROUP INC (2.13M shares), FMR LLC (1.93M shares), WELLINGTON MANAGEMENT GROUP LLP (1.86M shares), and BARROW HANLEY MEWHINNEY & STRAUSS LLC (1.84M shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.